Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
About this item
Full title
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
Author / Creator
Publisher
United States
Journal title
The New England journal of medicine, 2005-06, Vol.352 (24), p.2499-2507
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Selective blockade of interactions between leukocytes and vascular endothelium in the gut is a promising strategy for the treatment of inflammatory bowel diseases.
We conducted a multicenter, double-blind, placebo-controlled trial of MLN02, a humanized antibody to the alpha4beta7 integrin, in patients with active ulcerative colitis. We randomly...
Alternative Titles
Full title
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67936788
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67936788
Other Identifiers
E-ISSN
1533-4406
